Author(s): Ashok. P, Meyyanathan. S. N, R. Vadivelan, Jawahar. N

Email(s): Jeeashok77@gmail.com

DOI: 10.5958/2231-5659.2021.00001.1   

Address: Ashok. P1*, Meyyanathan. S. N1, R. Vadivelan2, Jawahar. N3
1Department of Pharmaceutical Analysis, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamil Nadu, India.
2Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamil Nadu, India.
3Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamil Nadu, India.
*Corresponding Author

Published In:   Volume - 11,      Issue - 1,     Year - 2021


ABSTRACT:
Nifedipine is a dihydropyridine calcium channel antagonist initially prescribed for treatment of angina pectoris and hypertension. The drug belongs to BCS Class-2 drug, is poorly water soluble drug, it suffers from a poor aqueous solubility, hence the delays its onset of action. Therefore, the purpose of the research study is to adopt the nanotechnology to formulate nanoparticles that improve the rate of dissolution of drug and to get desired bioavailability of nifedipine. Nanosuspensions were prepared by Solid Lipid NanoParticles method in the presence of selected stabilizers at different concentrations. The nanosuspensions were determined for their particle size of drug, zeta potential of drug, drug content and drug dissolution. The selected formula was freeze dried and illustrated by scanning electron microscopy (SEM), FT-IR, differential scanning calorimetry (DSC), and pharmacokinetic study. The in vitro dissolution confirmed the rate of drug release greater compared to the pure drug. The optimum formula has a typical particle size of 225.56±4.65nm and zeta potential of -17.84±2.17 mV. The bioavailability parameters in the rabbits were enhanced by 2 folds when compared with the marketed tablets (Calcigard®). Solid lipid nanoparticles method was successfully employed to produce stable Nifedipine nanosuspension by using the suitable concentration of stabilizer (PVA, Tween 80, PVP and HPMC). From this study, it is concluded that formulation of Nifedipine nanosuspension may be a competent approach that boost the rate of dissolution and hence oral bioavailability of drug.


Cite this article:
Ashok. P, Meyyanathan. S. N, R. Vadivelan, Jawahar. N. Nanosuspensions by Solid Lipid Nanoparticles method for the Formulation and in vitro/in vivo characterization of Nifedipine. Asian J. Res. Pharm. Sci. 2021; 11(1):1-6. doi: 10.5958/2231-5659.2021.00001.1

Cite(Electronic):
Ashok. P, Meyyanathan. S. N, R. Vadivelan, Jawahar. N. Nanosuspensions by Solid Lipid Nanoparticles method for the Formulation and in vitro/in vivo characterization of Nifedipine. Asian J. Res. Pharm. Sci. 2021; 11(1):1-6. doi: 10.5958/2231-5659.2021.00001.1   Available on: https://ajpsonline.com/AbstractView.aspx?PID=2021-11-1-1


1.      Barratt GM, 2000. Therapeutic applications of colloidal drug carriers. Pharm Sci Tech Today, 3,163–169.

2.      Chiba Y, Kohri N, Iseki K, Miyazaki K, 1991. Improvement of dissolution and bioavailability for mebendazole, an agent for human echinococcosis, by pre- paring solid dispersion with polyethylene glycol. Chem Pharm Bull, 39, 2158–2160.

3.      White SR, 2005. Acute dystonic reaction and the neuroleptic malignant syndrome. J Pharm Practice, 18, 175-83.

4.      Moschwitzer J, Achleitner G, Pomper H, Muller RH, 2004. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspensions. Eur J Pharm Biopharm, 58, 615-9.

5.      Wongmekiat A, Tozuka Y, Oguchi T, Yamamoto K, 2002. Formation of fine drug particles by co-grinding with cyclodextrin. I. the use of ßcyclodextrin anhydrate and hydrate. Pharm Res, 19, 1867-72.

6.      Itoh K, Pongpeerapat A, Tozuka Y, Oguchi T, Yamamoto K, 2003. Nanoparticle formation of poorly water soluble drugs from ternary ground mixtures with PVP and SDS. Chem Pharm Bull, 51, 171-4.

7.      Keck CM, Muller RH, 2006. Drug nanocrystals of poorly soluble drugs produced by high-pressure homogenization. Eur J Pharm Biopharm, 62, 3-16.

8.      Chorny M, Fishbein I, Danenberg HD, Golomb G, 2002. Lipophilic drug loaded nanospheres prepared by na- noprecipitation: effect of formulation variables on size, drug recovery, and release kinetics. J Controlled Release, 83, 389-400.

9.      Kumar MP, Rao YM, Apte S, 2008. Formulation of nanosuspensions of albendazole for oral administration. Curr Nanoscience, 4, 53-8.

10.   Van Eerdenbrugh B, Vermant J, Martens JA, Froyen L, Van Humbeeck J, Augustijns P, 2009. A screening study of surface stabilization during the production of drug nanocrystals. J Pharm Sci, 98, 2091-103.

11.   Merisko-Liversidge E, Sarpotdar P, Bruno J, Hajj S, Wei L. Peltier N, et al. 1996. Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm Res, 13, 272- 8.

12.   Saindane, 2013.Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization. AAPS Pharm Sci Tech, 14, 189- 99.

13.   Wei L, Yonggang Y, Yongshou T, Xinlan X, Yang C, Liwei M, et al. 2011.Preparation and in vitro/in vivo evalua- tion of revaprazan hydrochloride nanosuspension. Int J Pharm, 408, 157–62.

Recomonded Articles:

Author(s): Mohd. Yaqub Khan, Maryada Roy, Imtiyaz Ahmad, Irfan Aziz, Manju Panday

DOI: 10.5958/2231-5659.2015.00024.7         Access: Open Access Read More

Author(s): Saudagar R. B., Sarika V. Khandbahale

DOI: 10.5958/2231-5659.2017.00005.4         Access: Open Access Read More

Author(s): Rajashri R. Kulkarni, Dipti G. Phadtare, Ravindra B. Saudagar

DOI: 10.5958/2231-5659.2016.00019.9         Access: Open Access Read More

Author(s): Muhammed Jameel VP, Ravikumar, Narayanaswamy VB

DOI: 10.5958/2231-5659.2016.00017.5         Access: Open Access Read More

Author(s): Ismail Hussain, Ravikumar, Narayanaswamy VB, Injamamul Haque, Mohibul Hoque

DOI: 10.5958/2231-5659.2016.00030.8         Access: Open Access Read More

Author(s): K.Vijaya Sri, Guda Santhoshini, D. Ravi Sankar, K.Niharika

DOI: 10.5958/2231-5659.2018.00005.X         Access: Open Access Read More

Author(s): Girishchandra R. Mandake, Indrajit S. Patil, Omkar A Patil, Manoj M. Nitalikar, Shriniwas K Mohite

DOI: 10.5958/2231-5659.2018.00012.7         Access: Open Access Read More

Author(s): Ameena Samreen, Mohammed Riyaz, Amtul Asiya, Nuha Rasheed, Abdul Saleem Mohammad

DOI: 10.5958/2231-5659.2017.00007.8         Access: Open Access Read More

Author(s): D.M. Shinkar, Rohan S. Gadakh, R.B. Saudagar

DOI: 10.5958/2231-5659.2016.00015.1         Access: Open Access Read More

Author(s): Sana Banu, Syeda Ayesha Farheen

DOI: 10.5958/2231-5659.2019.00015.8         Access: Open Access Read More

Author(s): Rohan R. Vakhariya, Swati S. Talokar, V. R. Salunkhe, C. S. Magdum

DOI: 10.5958/2231-5659.2017.00008.X         Access: Open Access Read More

Author(s): Pramod Patil, Someshwara Rao B, Suresh V Kulkarni, Basavaraj, Chetan Surpur , Anand Ammanage

DOI:         Access: Open Access Read More

Author(s): Shiba S. Morris, Jeyabalan G, A. K. Jha, Shekhar Verma, Yashwant Swarnkar

DOI:         Access: Open Access Read More

Author(s): Dasari Nirmala, Enjamuri Aslesha , M. Sudhakar

DOI:         Access: Open Access Read More

Author(s): D.M. Shinkar, Aarif S. Khatik, R.B. Saudagar

DOI: 10.5958/2231-5659.2016.00022.9         Access: Open Access Read More

Author(s): Surekha Baghel, Bina Gidwani, Chanchal Deep Kaur

DOI: 10.5958/2231-5659.2017.00009.1         Access: Open Access Read More

Author(s): Smita Kolhe, Praveen Chaudhari, Dhananjay More

DOI:         Access: Open Access Read More

Asian Journal of Research in Pharmaceutical Sciences (AJPSci) is an international, peer-reviewed journal, devoted to pharmaceutical sciences....... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231-5659 


Recent Articles




Tags